Susceptibility testing of Cryptococcus neoformans using the urea broth microdilution method

Mycoses

Volumn 41, Issue 1-2, 1998, Pages 41-44

  Nakamura, Y ^a   Kano, R ^a   Watanabe, S ^a   Takahashi, H ^a   Hasegawa, A ^b  

^a TEIKYO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cryptococcus neoformans; Fluconazole; Itraconazole; Microdilution; Susceptibility testing; Terbinafine; Urea broth; Urease activity

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; TERBINAFINE; UREASE;

ANTIFUNGAL ACTIVITY; ARTICLE; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIUM; DRUG SENSITIVITY; ENZYME ACTIVITY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; TECHNIQUE;

FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 0031833479     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.1998.tb00374.x     Document Type: Article

References (8)

1. Espinel-Ingroff, A., Kish, Jr. C. W., Kerkering, T. M. et al. (1992) Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 30, 3138-3145.
2. Fromtling, R. A, Galgiani, J. N., Pfaller, M. A. et al. (1993) Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37, 39-45.
3. Anaissie, E. J., Paetznick, V. & Bodey, G. P. (1991) Fluconazole susceptibility testing of Candida albicans: microtiter method that is dependent of inoculum size, temperature and time of reading. Antimicrob. Agents. Chemother. 35, 1641-1646.
4. Yamaguchi, H., Uchida, K., Kume, H. et al. (1995) Report of the committee of clinical laboratory standards - 1994. Jpn J. Med. Mycol. 36, 62-64.
5. Kwon-Chung, K. J. & Bennett, J. E. (1992) Cryptococcosis. In: Kwon-Chung, K. J. & Bennett, J. E. (eds): Medical Mycology. Philadelphia: Lea & Febiger, pp. 397-411.
6. Kwon-Chung, K. J., Polacheck, I. & Bennett, J. E. (1982) Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J. Clin. Microbiol. 15, 535-537.
7. Pal, M., Onda, C. & Hasegawa, A. (1991) Sexual compatibility of clinical and environmental isolates of Cryptococcus neoformans. Jpn J. Med. Mycol. 32, 101-106.
8. Mikami, Y., Sakamoto, T., Yazawa, K., Gonoi, T., Ueno, Y. & Hasegawa, S. (1993) Comparison of in vitro antifungal activity of itraconazole and hydroxy-itraconazole by colorimetric MTT assay. mycoses 37, 27-33.